 b Either commit to continued abstinence from heterosexual intercourse which must be reviewed on a monthly basis or agree to use, and be able to comply with, effective contraception without interruption, 28 days prior to starting study drug, during the study therapy including dose interruptions, and for 28 days after discontinuation of study therapy. 